Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 110

Results For "science"

2031 News Found

Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS
Healthcare | October 11, 2023

Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS

Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells


Ayurveda benefits animal, plant and human life, says Sonowal
News | October 11, 2023

Ayurveda benefits animal, plant and human life, says Sonowal

Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush


Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants
News | October 11, 2023

Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants

Alignment of carbon-fiber can be controlled during the 3D printing process


Zydus receives final approval from the USFDA for Sugammadex Single-Dose Vial
Drug Approval | October 09, 2023

Zydus receives final approval from the USFDA for Sugammadex Single-Dose Vial

Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide


India has taken a lead in Preventive and Integrated Healthcare, says Dr Jitendra Singh
Digitisation | October 09, 2023

India has taken a lead in Preventive and Integrated Healthcare, says Dr Jitendra Singh

Dr. Singh proposes upskilling medicos with AI, Quantum and other newer technologies to meet the changing requirements of patient care


Mitsui invests in Lokavant Holdings
News | October 09, 2023

Mitsui invests in Lokavant Holdings

Lokavant provides clinical trial intelligence


Asahi Kasei Pharma files application for approval to manufacture and sell Cresemba Capsule
Drug Approval | October 05, 2023

Asahi Kasei Pharma files application for approval to manufacture and sell Cresemba Capsule

The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg


Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets
Drug Approval | October 05, 2023

Strides receives USFDA approval for Efavirenz, Emtricitabine & Tenofovir Disoproxil Fumurate tablets

The approval adds to a list of products that Strides has approved in this therapeutic category through the PEPFAR pathway taking the total to 15 products


Strides receives USFDA approval for Icosapent Ethyl capsules
Drug Approval | October 04, 2023

Strides receives USFDA approval for Icosapent Ethyl capsules

The product is bioequivalent and therapeutically equivalent to the RLD, Vascepa of Amarin


Zydus announces IND clearance of a novel Anti-PCSK9 candidate
Clinical Trials | October 03, 2023

Zydus announces IND clearance of a novel Anti-PCSK9 candidate

Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity